Ind-Swift Laboratories Ltd.
INDSWFTLAB Share PricePharmaceuticals & Drugs
₹97.62
-0.3 (-0.3%)
As on December 15, 2025
Exchange Scrips: BSE532305NSEINDSWFTLABISININE915B01019
Market Cap ₹ 786 Cr
P/E Ratio 2.68
Dividend Yield N/A
Performance
Market performance
Open99.5
High99.5
Volumes1,01,882
Prev97.62
Low95.99
As on2025-12-15
Historical performance
1 Year High124
3 Year High186
5 Year High186
1 Year Low68.72
3 Year Low53.95
5 Year Low52.65
Fundamentals
Company Valuation
Market Cap (₹Cr)
786
Face Value (₹)
10
P/E Ratio
2.68
Dividend Yield
N/A
Investment Returns
1 Year
-13.9%
3 Years
46.6%
5 Years
60.6%
10 Years
207.5%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 95.09 | Bullish |
| 10-DMA | 94.62 | Bullish |
| 20-DMA | 95.53 | Bullish |
| 50-DMA | 99.87 | Bearish |
| 100-DMA | 101.17 | Bearish |
| 200-DMA | 96.33 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 21 | 18 | 18 | 18 | 18 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 21 | 18 | 18 | 18 | 18 |
| Public Investors | 43759 | 28691 | 28099 | 28734 | 28865 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 2.68.
- 3Y Stock Price CAGR of the stock is 14.8.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹620 Million.
- The company generated revenue of ₹5617 Million in the previous financial year.
Ind-Swift Laboratories Ltd.
97.62-0.3 (-0.3%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 878588.8
No. of Shares: 9000 (Approx)
Performance:-12.1%
P/L: ₹-121411.2
Top Gainers
| Symbol | Change% |
|---|---|
| TAINWALCHM | 191.9(20%) |
| TVVISION | 9.32(20%) |
| REFEX | 299.4(18%) |
| MAHAPEXLTD | 111.44(17%) |
| VIPULLTD | 11.92(16%) |
Peer Comparison
Get Your Portfolio Reviewed
